Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Goyang-si
Clinical trial register · South Korea

Clinical Trials in Goyang-si, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3401 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:18 UTC
3401
Studies in scope
all four open statuses
1867
Recruiting now
open to new participants
507
Lead sponsors
across recruiting studies
Top sites
Seoul 2859 Daegu 553 Seongnam-si 482 Busan 469 Goyang-si 397

Trials with a site in Goyang-si

397 of 3401 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Not yet open
Intuitive Surgical
Observational
151
Goyang-si, Daejeon, Seoul, Ulsan
2027-01
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Namdong-gu, Bucheon-si, Goyang-si, Suwon, Busan, Haeundae-gu, Seoul, Dong-gu, Ulsan
2026-12-16
Not yet open
Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism
NCT07852637Venous Thromboembolism, Active Cancer
Samsung Medical Center
Phase 4
2,300
Goyang-si, Busan, Goyang, Gwangmyeong, Hwasun, Jeonju, Seoul
2026-11-01
Recruiting
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
NCT07816666Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer, Platinum-sensitive Relapsed Primary Peritoneal Cancer
AstraZeneca
Phase 3
600
Goyang-si, Seoul
2026-09-24
Recruiting
BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA
NCT07570394Chronic Obstructive Pulmonary Disease (COPD), Asthma
AstraZeneca
Observational
600
Chuncheon, Daegu, Goyang-si, Gwangmyeong, Jinju, Seongnam-si, Seoul, Wŏnju
2026-09-17
Recruiting
Post-marketing Surveillance Study for the Safety of Efluelda® Pre-filled Syringe
NCT07282795Influenza Immunization, Healthy Volunteers
Sanofi
Observational
670
Goyang-si, Gunpo, Busan, Daegu, Incheon, Seoul
2026-09-17
Recruiting
AstraZeneca
Phase 3
950
Busan, Daegu, Goyang-si, Gyeonggi-do, Seongnam-si, Seoul, Yangsan
2026-09-16
Recruiting
Bristol-Myers Squibb
Phase 3
850
Cheongju-si, Buk-Gu, Dalseo, Goyang-si, Seongnam-si, Hwasun-Gun, Seocho -Gu, Songpa-Gu
2026-09-08
Not yet open
LucasBio
Phase 1/2
42
Seoul, Daegu, Goyang-si, Hwasun, Ulsan
2026-09-01
Recruiting
AstraZeneca
Phase 3
7,000
Anyang-si, Busan, Cheonan-si, Daejeon, Goyang-si, Guri-si, Junggu, Seoul
2026-08-21
Recruiting
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
NCT07625644Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma, Sclc
SystImmune Inc.
Phase 3
550
Goyang-si, Gyeonggi-do, Jeongnam, Seoul, Suwon
2026-08-04
Recruiting
National Cancer Center, Japan
Phase 2
136
Goyang-si, Suwon, Seocho, Songpa-dong
2026-07-15
Recruiting
MedPacto, Inc.
Observational
400
Goyang-si, Seoul
2026-07-13
Not yet open
Hanmi Pharmaceutical Company Limited
Phase 3
256
Goyang-si
2026-07-06
Recruiting
AstraZeneca
Phase 3
2,000
Busan, Goyang-si, Guri-si, Gwangju, Gyeonggi-do, Seoul, Suwon, Yangsan
2026-07-06
Recruiting
AstraZeneca
Phase 3
4,500
Busan, Daegu, Goyang-si, Gyeonggi-do, Incheon, Jongno-gu, Seoul, Suwon
2026-06-29
Recruiting
Merck Sharp & Dohme LLC
Phase 3
310
Goyang-si, Suwon, Cheongju-si, Daegu, Seoul
2026-06-18
Recruiting
AstraZeneca
Phase 3
150
Cheonan-si, Daegu, Goyang-si, Hwasun-eup, Incheon, Seongbuk-Gu, Seongnam-si, Seoul
2026-06-15
Not yet open
Seoul National University Hospital
Not applicable
2,301
Chuncheon, Gangneung, Anyang-si, Bucheon-si, Goyang-si, Changwon, Busan, Daegu
2026-06-15
Active, closed
Seoul National University
Observational
27,000
Goyang-si, Seoul
2026-06-01
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Goyang-si, Gyeonggi-do, Hwasun, Seoul
2026-05-31
Recruiting
Mirati Therapeutics Inc.
Phase 2
170
Goyang-si, Seoul
2026-05-06
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
1,020
Goyang-si, Seongnam-si, Daegu, Seoul
2026-05-06
Recruiting
AstraZeneca
Phase 3
670
Goyang-si, Seoul
2026-05-04
Not yet open
Hemodynamic Effects of Remimazolam vs Propofol During Robot-assisted Gynecologic Surgery
NCT07251101Anesthesia, Intravenous, Hemodynamic Stability, Gynecologic Surgery
Ilsan Cha hospital
Not applicable
58
Goyang-si
2026-05-02
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 3
420
Daegu, Goyang-si, Seoul
2026-04-17
Recruiting
Incyte Corporation
Phase 3
588
Goyang-si, Seongnam-si, Seoul
2026-04-09
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
60
Goyang-si, Seoul
2026-03-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
400
Goyang-si, Suwon, Daegu, Seoul
2026-03-18
Recruiting
Incyte Corporation
Phase 3
700
Changwon-si, Goyang-si, Seongnam, Seongnam-si, Seoul, Suwon
2026-03-05
Recruiting
Hansu Bae
Not applicable
84
Goyang-si
2026-02-25
Recruiting
Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA)
NCT07161479Gastric Adenoma, Stomach Neoplasms, Precancerous Conditions, Dysplasia Stomach
Samsung Medical Center
Not applicable
160
Goyang-si, Seoul
2026-01-20
Recruiting
Pharmacopuncture for Aromatase Inhibitor Induced Arthralgia (AIA)
NCT07789717Breast Cancer, Aromatase Inhibitor, Aromatase Inhibitor Induced Arthralgia
Ilsan Cha hospital
Not applicable
30
Daejeon, Goyang-si, Incheon
2026-01-05
Not yet open
Inha University Hospital
Phase 4
1,898
Incheon, Ansan, Bucheon-si, Busan, Cheonan, Goyang, Goyang-si, Guri-si
2026-01-01
Recruiting
AstraZeneca
Phase 3
1,100
Busan, Daegu, Goyang-si, Seongnam-si, Seoul, Suwon, Yangsan
2025-12-29
Recruiting
Taiho Oncology, Inc.
Phase 3
360
Daegu, Seongnam-si, Suwon, Cheongju-si, Goyang-si, Pusan, Yangsan, Jinju
2025-12-22
Recruiting
Janssen Research & Development, LLC
Phase 3
800
Goyang-si, Seoul
2025-12-19
Recruiting
Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors
NCT07358806Solid Tumor, Breast Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer
Oscotec Inc.
Phase 1
51
Goyang-si, Seongnam-si, Seoul
2025-12-18
Recruiting
The KN510713 Study in Combination With mFOLFIRINOX
NCT07114861Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
New Cancer Cure-Bio Co.,Ltd.
Phase 1/2
30
Goyang-si
2025-12-16
Recruiting
Merck Sharp & Dohme LLC
Phase 2
180
Goyang-si, Seongnam-si, Cheongju-si, Seoul
2025-12-12
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
Eli Lilly and Company
Phase 3
450
Goyang-si, Junggu, Namdong-gu, Seongnam, Seoul
2025-12-12
Recruiting
Incyte Corporation
Phase 3
466
Ansan-si, Changwon-si, Daegu, Goyang-si, Seongnam-si, Seoul
2025-12-09
Recruiting
Syndax Pharmaceuticals
Phase 3
468
Busan, Daegu, Goyang-si, Seoul
2025-11-25
By invitation
Novo Nordisk A/S
Observational
500
Goyang-si, Seongnam-si, Suwon, Uijeongbu-si, Yangsan, Busan, Daegu, Daejeon
2025-11-10
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Busan, Daegu, Goyang-si, Seongnam-si, Suwon, Yongin-si, Seoul
2025-11-03
Recruiting
AstraZeneca
Phase 3
400
Goyang-si, Incheon, Seoul, Suwon
2025-10-31
Recruiting
AstraZeneca
Phase 3
100
Bukgu, Goyang-si, Seoul
2025-10-30
Recruiting
BioNTech SE
Phase 3
558
Cheonan, Cheongju-si, Goyang-si, Seongnam-si, Seoul, Suwon
2025-10-30
Recruiting
Daiichi Sankyo
Phase 3
686
Cheongju-si, Goyang-si, Jinju, Seongnam, Seoul, Suwon
2025-10-24
Recruiting
Eli Lilly and Company
Phase 3
1,630
Daegu, Goyang-si, Seongnam, Seoul, Suwon
2025-10-22
Recruiting
AstraZeneca
Observational
130
Busan, Daejeon, Goyang-si, Guri-si, Incheon, Seongnam-si, Seoul, Suwon
2025-10-15
Recruiting
Pfizer
Phase 3
680
Cheongju-si, Goyang-si, Seongnam, Seongnam-si, Suwon, Haeundae-gu, Dongjak-gu, Seoul
2025-09-29
Recruiting
Pfizer
Phase 3
1,000
Hwasun-gun, Goyang-si, Seongnam, Seoul, Deagu, Junggu
2025-09-28
By invitation
Patients With High-grade Pancreatic Neuroendocrine Tumors
NCT07121478Neuroendocrine Tumor of Pancreas, Pancreatic Neuroendocrine Tumors
National Cancer Center, Korea
Phase 2
46
Goyang-si
2025-09-23
Recruiting
National Cancer Center, Korea
Phase 2
80
Goyang-si
2025-09-10
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Anyang-si, Busan, Changwon-si, Cheongju-si, Daegu, Daejeon, Goyang-si, Gwangju
2025-09-06
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Daejeon, Goyang-si, Hwasungun, Seoul
2025-09-02
Not yet open
National Cancer Center, Korea
Not applicable
54
Goyang-si
2025-08-22
Recruiting
AstraZeneca
Phase 3
700
Busan, Daegu, Goyang-si, Seongnam-si, Seoul
2025-08-06
Recruiting
AstraZeneca
Phase 3
800
Goyang-si, Gwangjin-gu, Seoul, Songpa-gu, Suwon
2025-08-01
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
298
Goyang-si, Seoul
2025-07-30
Recruiting
Daiichi Sankyo
Phase 2
130
Busan, Daegu, Goyang-si, Incheon, Jeonju, Seongnam, Seoul, Suwon
2025-07-18
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
NCT06765109Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
Nuvalent Inc.
Phase 3
450
Cheongju-si, Goyang-si, Incheon, Seoul
2025-07-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Goyang-si, Seongnam-si, Suwon, Gangnam, Songpa-gu, Buk-Gu, Seoul
2025-07-16
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
Merck Sharp & Dohme LLC
Phase 3
2,400
Goyang-si, Kyonggi-do, Taegu, Seoul
2025-06-30
Recruiting
Streamlining Radioembolization for CCC and Metastatic Liver Cancer
NCT07043387Metastatic Colorectal Carcinoma (mCRC), Metastatic Liver Cancer, Cholangiocarcinoma
Seoul National University Hospital
Observational
60
Goyang-si, Seoul
2025-06-22
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Daejeon, Goyang-si, Gyeonggi-do, Seoul
2025-06-04
Recruiting
AstraZeneca
Phase 3
15,100
Bucheon-si, Busan, Changwon-si, Daegu, Daejeon, Goyang-si, Gwangju, Gwangmyeong
2025-06-04
Recruiting
Efficacy and Safety Study of Isuzinaxib in Subjects With DKD
NCT06962098Diabetic Kidney Disease (DKD)
Aptabio Therapeutics, Inc.
Phase 2
186
Ansan-si, Busan, Cheonan, Daegu, Goyang-si, Guri-si, Gwangmyeong, Incheon
2025-05-26
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
500
Goyang-si, Seongnam-si, Suwon, Hwasungun, Cheongju-si, Seocho-gu, Daegu, Incheon
2025-05-22
Recruiting
AstraZeneca
Phase 3
1,220
Busan, Goyang-si, Gyeonggi-do, Seongnam-si, Seoul
2025-05-06
Recruiting
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
NCT06730347Platinum-resistant Ovarian Cancer, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, Clear Cell Adenocarcinoma of Ovary
MacroGenics
Phase 2
80
Goyang-si, Seongnam-si, Seoul
2025-05-01
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
605
Goyang-si, Seoul
2025-04-15
Recruiting
A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.
NCT06902545Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Korea, Inc.
Observational
377
Goyang-si, Suwon, Uijeongbu-si, Yangsan, Hwasun Gun, Daejeon, Seoul
2025-04-03
Recruiting
Daiichi Sankyo
Phase 3
510
Daegu, Goyang-si, Hwasun-gun, Incheon, Seongnam-si, Seoul
2025-03-27
Recruiting
Eli Lilly and Company
Phase 3
700
Bupyeong-gu, Busan, Cheongju-si, Daegu, Deagu, Eunpyeong-gu, Gangnam-gu, Goyang-si
2025-03-27
Recruiting
Viscum Album for TNBC on Adjuvant Pembrolizumab
NCT06920810Breast Cancer, Triple Negative Breast Cancer
Ilsan Cha hospital
Phase 4
40
Goyang-si
2025-03-19
Active, closed
Celgene
Phase 3
960
Goyang-si, Seongnam, Seoul
2025-03-13
Recruiting
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
NCT06687941Neoplasms, Carcinoma, Hepatocellular, Carcinoma, Non-Small-Cell Lung, Liver Neoplasms
Aptamer Sciences, Inc.
Phase 1
70
Goyang-si, Seongnam, Seoul
2025-03-11
Recruiting
AstraZeneca
Phase 3
5,000
Ansan-si, Anyang-si, Busan, Cheonan-si, Goyang-si, Gwangju, Seongnam-si, Seoul
2025-03-03
Recruiting
AstraZeneca
Phase 3
840
Daegu, Goyang-si, Gyeonggi-do, Jeonnam, Seoul
2025-03-01
Recruiting
Daiichi Sankyo
Phase 3
726
Cheongju-si, Daegu, Goyang-si, Hwasun-gun, Incheon, Jeonju, Seongnam, Seongnam-si
2025-02-27
Recruiting
BioNTech SE
Phase 3
621
Seoul, Goyang-si, Suwon, Jinju, Incheon, Cheongju-si
2025-02-03
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Bicara Therapeutics
Phase 2/3
650
Busan, Goyang-si, Hwasun, Seongnam, Seoul
2025-01-28
Recruiting
BioNTech SE
Phase 2/3
1,580
Cheongju-si, Daejeon, Goyang-si, Incheon, Jinju, Seongnam-si, Seoul, Suwon
2025-01-07
Active, closed
Pfizer
Phase 3
1,035
Seongnam-si, Incheon, Goyang-si, Seongnam, Gangnam-gu, Seoul
2025-01-06
Active, closed
Daiichi Sankyo
Phase 2
335
Goyang-si, Seoul
2025-01-06
Not yet open
Digital CBT-I for Chronic Insomnia
NCT06695000Insomnia Chronic, Insomnia Disorder
WELT corp
Not applicable
120
Goyang-si, Yongin-si, Seoul
2025-01
Recruiting
A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors
NCT06747585Squamous Non-small-cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma
Alentis Therapeutics AG
Phase 1/2
235
Goyang-si, Seoul
2024-12-16
Active, closed
Vicore Pharma AB
Phase 2
378
Bucheon-si, Busan, Goyang-si, Seoul
2024-12-09
Recruiting
Novo Nordisk A/S
Phase 2
465
Goyang-si, Busan, Gyeonggi-do, Seoul
2024-12-02
Active, closed
Genmab
Phase 3
191
Suwon, Cheongju-si, Daegu, Goyang-si, Seoul
2024-11-25
Recruiting
National Cancer Center, Korea
Phase 2
82
Goyang-si
2024-11-19
Active, closed
Master Protocol for Basket Clinical Trials of Targeted Therapies Based on Proteome and Whole Exome Sequencing Screening in Patients With Advanced Solid Tumors
NCT07891169Advanced Solid Tumors, Metastatic Solid Tumors, Locally Advanced Solid Tumors, Recurrent Solid Tumors
National Cancer Center, Korea
Not applicable
2,800
Goyang, Goyang-si
2024-11-18
Recruiting
National Cancer Center, Korea
Not applicable
50
Goyang-si
2024-11-04
Active, closed
A Study of ZW191 in Participants With Solid Tumors
NCT06555744Advanced Solid Tumors
Zymeworks BC Inc.
Phase 1
145
Goyang-si, Seongnam-si, Seoul
2024-10-30
Recruiting
Pfizer
Phase 3
900
Hwasun, Goyang-si, Seoul, Daegu, Junggu
2024-10-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
680
Goyang-si, Suwon, Seoul
2024-10-21
Active, closed
Pfizer
Phase 3
609
Hwasun, Goyang-si, Seoul, Daegu
2024-10-21
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Cheongju-si, Namdong-gu, Hwasun, Goyang-si, Seongnam-si, Yangsan, Busan, Seoul
2024-10-07
Recruiting
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NCT06528314NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Akero Therapeutics, Inc
Phase 3
2,150
Nam-Gu, Daegu, Wŏnju, Incheon, Goyang-si, Seoul
2024-10-04
Recruiting
Ferring Pharmaceuticals
Phase 3
454
Goyang-si, Yangsan, Hwasun, Seoul
2024-10-01
Active, closed
Genmab
Phase 3
699
Busan, Goyang-si, Hwasun, Seoul, Suwon
2024-09-25
Recruiting
AbbVie
Observational
3,000
Busan, Daejeon, Gangwon-do, Gwangju, Ansan-si, Goyang, Goyang-si, Hwaseong
2024-09-24
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Anyang, Cheonan, Daegu, Daejeon, Gangwon-do, Goyang-si, Seongnam-si, Seoul
2024-08-30
Active, closed
Boehringer Ingelheim
Phase 3
8,371
Ansan-si, Busan, Cheonan-si, Cheongju-si, Daegu, Deagu, Goyang-si, Guri-si
2024-08-30
Recruiting
AstraZeneca
Phase 3
1,018
Busan, Goyang-si, Jeonnam, Seoul
2024-08-07
Active, closed
BioNTech SE
Phase 2
110
Cheongju-si, Daegu, Goyang-si, Incheon, Jinju, Seoul, Suwon
2024-08-05
Recruiting
Sanofi
Phase 1
96
Busan, Goyang-si, Seoul
2024-07-08
Active, closed
Genmab
Phase 3
621
Busan, Goyang-si, Hwasun, Seoul, Soeul, Suwon
2024-06-25
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Bucheon-si, Goyang-si, Seongnam-si, Suwon, Yangsan, Busan, Cheongju-si, Daegu
2024-06-25
Recruiting
Allogene Therapeutics
Phase 2
250
Seogu, Goyang-si, Suwon, Hwasun, Seoul
2024-06-18
Active, closed
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
NCT06157892Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
54
Seongnam-si, Busan, Goyang-si, Seoul, Cheongju-si, Incheon, Suwon
2024-05-20
Recruiting
AstraZeneca
Phase 3
582
Goyang-si, Namdong-gu, Seoul, Suwon
2024-04-29
Recruiting
CSL Behring
Phase 2/3
3,110
Ilsan-gu, Anyang-si, Daegu, Gangnam-gu, Goyang-si, Guri-si, Gwangju, Seoul
2024-04-27
Recruiting
CMG Pharmaceutical Co. Ltd
Phase 3
240
Anyang, Buchon, Busan, Cheonan, Daegu, Daejeon, Goyang-si, Guri-si
2024-04-19
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
Sanofi
Phase 3
2,500
Goyang-si, Seoul
2024-04-16
Active, closed
Amgen
Phase 4
32
Goyang-si, Seoul
2024-04-02
Recruiting
Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma
NCT06168292Biliary Tract Carcinoma, Radiotherapy, Radio-frequency Ablation
National Cancer Center, Korea
Not applicable
53
Goyang-si
2024-04-01
Active, closed
AstraZeneca
Phase 3
2,554
Ansan-si, Anyang-si, Busan, Cheonan-si, Daejeon, Goyang-si, Gwangju, Seoul
2024-03-29
By invitation
Active Surveillance for Low-risk Papillary Thyroid Carcinoma
NCT06261190Thyroid Cancer, Papillary Thyroid Carcinoma
National Cancer Center, Korea
Observational
499
Goyang-si, Seongnam, Seoul
2024-03-06
Recruiting
Daiichi Sankyo
Phase 2/3
860
Goyang-si, Seongnam, Seongnam-si, Seoul
2024-02-27
Recruiting
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
NCT06246123Arthritis, Rheumatoid, Colitis, Ulcerative
Eisai Korea Inc.
Observational
2,040
Cheonan, Chuncheon, Wŏnju, Ansan, Bucheon-si, Goyang-si, Gwangmyeong, Seongnam-si
2024-02-27
Recruiting
GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
NCT06265025Head and Neck Cancer, Malignant Melanoma, Colorectal Cancer, Renal Cell Carcinoma
GeneMedicine Co., Ltd.
Phase 1/2
125
Goyang-si, Seoul
2024-02-20
Active, closed
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
NCT05853575Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung
Mirati Therapeutics Inc.
Phase 2
200
Goyang-si, Seoul
2024-02-01
Active, closed
Yonsei University
Phase 2
198
Seoul, Goyang-si, Seongnam-si
2024-01-22
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
NCT06162221Non-Small Cell Lung Cancer, NSCLC, KRAS, NRAS, HRAS-mutated NSCLC, KRAS G12C-mutated Solid Tumors, Lung Cancer, Lung Cancer Stage IV, Advanced Solid Tumor, Cancer
Revolution Medicines, Inc.
Phase 1/2
616
Seoul, Goyang-si, Seongnam-si
2024-01-18
Recruiting
Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers
NCT06135896Unresectable Pancreatic Cancer, Unresectable Bile Duct Carcinoma, Unresectable Biliary Tract Carcinoma
National Cancer Center, Korea
Phase 2
98
Goyang-si
2024-01-16
Recruiting
Daiichi Sankyo
Phase 3
75
Daegu, Goyang-si, Seoul
2024-01-05
Recruiting
National Cancer Center, Korea
Not applicable
120
Goyang-si, Seoul
2023-12-27
Active, closed
Sanofi
Phase 3
943
Goyang-si, Seongnam-si, Seoul
2023-12-27
Recruiting
Eli Lilly and Company
Phase 3
1,264
Cheongju-si, Daegu, Deagu, Gangnam-gu, Goyang-si, Hwasun, Seoul, Suwon
2023-12-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Goyang-si, Seongnam, Buk-gu, Pusan, Seoul
2023-12-18
Recruiting
AstraZeneca
Phase 3
1,145
Goyang-si, Gyeonggi-do, Incheon, Seoul, Suwon
2023-12-14
Active, closed
Sanofi
Phase 3
1,655
Goyang-si, Seongnam-si, Seoul
2023-12-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
868
Goyang-si, Seongnam, Suwon, Cheongju-si, Daegu, Seoul
2023-12-06
Recruiting
Akero Therapeutics, Inc
Phase 3
1,650
Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2023-12-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
556
Hwasun, Goyang-si, Seongnam, Suwon, Yangsan, Cheongju-si, Busan, Junggu
2023-11-12
Active, closed
AstraZeneca
Phase 3
1,835
Ansan-si, Busan, Cheonan-si, Daegu, Goyang-si, Seoul
2023-11-07
Recruiting
Astellas Pharma Korea, Inc.
Observational
228
Goyang-si, Suwon, Jeollanam-do, Jeonju, Busan, Daegu, Daejeon, Incheon
2023-11-01
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Goyang-si, Jongno-gu, Songpa-gu, Yongsan-gu, Dong-gu, Bucheon-si, Bucheonsi Weonmigu, Busan
2023-10-25
Recruiting
A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.
NCT06126016Chronic Kidney Disease 5D, Secondary Hyperparathyroidism
Boryung Pharmaceutical Co., Ltd
Observational
1,000
Goyang-si
2023-10-19
Active, closed
Genentech, Inc.
Phase 2
260
Goyang-si, Gyeonggi-do, Seocho, Seongnam-si, Seoul, Songpa-gu
2023-10-18
Active, closed
AstraZeneca
Phase 3
5,511
Cheonan-si, Daegu, Goyang-si, Seongnam-si, Seoul
2023-10-05
Recruiting
Pierre Fabre Medicament
Phase 1/2
345
Cheongju-si, Goyang-si, Seongnam-si, Seoul
2023-09-26
Recruiting
A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
NCT05428345Ulcerative Colitis, Crohn's Disease, Inflammatory Bowel Disease (IBD)
Takeda
Observational
600
Goyang-si
2023-09-25
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
412
Goyang-si, Seongnam-si, Suwon, Hwasun-gun, Iksan-si, Busan, Incheon, Seoul
2023-09-22
Recruiting
AstraZeneca
Phase 3
800
Daegu, Goyang-si, Gyeonggi-do, Seoul
2023-09-22
Active, closed
Hoffmann-La Roche
Phase 3
687
Goyang-si, Gyeonggi-do, Jeollanam-do, Seoul, Ulsan
2023-09-14
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Goyang-si, Jongno-gu, Yongsan-gu, Dong-gu, Bucheon-si, Bucheonsi Weonmigu, Busan, Donggu
2023-09-14
Active, closed
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
NCT05846893Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Coronary Stenosis
B. Braun Medical Industries Sdn. Bhd.
Not applicable
1,436
Daegu, Chuncheon, Donggu, Ansan-si, Goyang-si, Changwon, Seoul
2023-09-07
Recruiting
National Cancer Center, Korea
Phase 2
120
Suwon, Goyang-si, Seoul
2023-09-05
Recruiting
Ipsen
Phase 3
276
Bucheon-si, Busan, Daegu, Daejeon, Goyang-si, Gyeonggi-do, Incheon, Junggu
2023-08-31
Active, closed
Erasca, Inc.
Phase 1
86
Busan, Seoul, Goyang-si, Gyeonggi-do
2023-08-17
Recruiting
Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients
NCT06780748Breast Cancer, Locally Recurrent Breast Cancer, Sentinel Lymph Node Biopsy (SLNB), Reoperation
National Cancer Center, Korea
Phase 2
30
Goyang-si
2023-08-13
Recruiting
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
NCT05967689Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
Taiho Oncology, Inc.
Phase 2
220
Goyang-si, Suwon, Jinju, Incheon, Hwasun-gun, Seoul, Soeul
2023-07-31
Recruiting
J Ints Bio
Phase 1/2
150
Goyang-si, Cheongju-si, Seoul, Suwon
2023-07-30
Recruiting
National Cancer Center, Korea
Not applicable
128
Goyang-si
2023-07-06
Active, closed
OncoC4, Inc.
Phase 3
630
Cheongju-si, Daegu, Goyang-si, Seoul, Suwon
2023-06-28
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Busan, Goyang-si, Seongnam-si, Gyeonggi-do, Seoul, Ulsan
2023-06-22
Recruiting
Hoffmann-La Roche
Phase 3
200
Goyang-si, Gyeonggi-do, Seongnam-si, Seoul
2023-06-01
Recruiting
National Cancer Center, Korea
Phase 3
520
Sejong, Goyang-si, Suwon, Pusan, Seoul
2023-05-31
Active, closed
AstraZeneca
Phase 3
37
Cheongju-si, Donggu, Goyang-si, Seongnam-si, Seoul
2023-05-08
Recruiting
GC Biopharma Corp
Phase 3
105
Goyang-si, Suwon, Seoul, Busan, Daejeon
2023-04-13
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Anyang-si, Busan, Cheonan-si, Cheongju-si, Chuncheon, Daegu, Daejeon, Goyang-si
2023-04-11
Recruiting
AstraZeneca
Phase 3
4,300
Busan, Daegu, Donggu, Goyang-si, Jeonnam, Seongbuk-Gu, Seoul
2023-03-31
Active, closed
AbbVie
Phase 3
520
Goyang-si, Seongnam, Seongnam-si, Daegu, Seoul
2023-03-15
Active, closed
An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases
NCT05732402Lupus Nephritis, Immunoglobulin A Nephropathy, Membranous Nephropathy, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Alpine Immune Sciences, Inc.
Phase 1/2
72
Cheonan, Anyang-si, Goyang-si, Guri-si, Seoul, Suwon
2023-03-15
Active, closed
ModernaTX, Inc.
Observational
4,207
Wŏnju, Bucheon-si, Gimpo-si, Goyang-si, Gwangmyeong, Namyangju, Siheung, Yangju
2023-03-10
Active, closed
AstraZeneca
Phase 2
188
Busan, Cheongju-si, Daejeon, Goyang-si, Gyeonggi-do, Incheon, Seongnam-si, Seoul
2023-03-06
Active, closed
Pfizer
Phase 3
624
Namdong-gu, Goyang-si, Seongnam, Suwon, Seoul
2023-03-03
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Anyang-si, Busan, Daegu, Daejeon, Goyang-si, Gwangju, Incheon, Jeju Special
2023-02-15
Recruiting
Abion Inc
Phase 2
178
Goyang-si, Suwon, Dongjak, Seoul, Sinchon-dong, Cheongju-si, Incheon, Jinju
2023-01-17
Active, closed
Daiichi Sankyo
Phase 3
1,233
Cheongju-si, Daegu, Gangnam-Gu, Goyang-si, Jinju-si Gyeongsangnam-do, Seongnam-si, Seoul
2023-01-11
Active, closed
Hanmi Pharmaceutical Company Limited
Phase 1
170
Goyang-si, Seoul
2023-01-11
Active, closed
Exelixis
Phase 3
317
Busan, Daegu, Daejeon, Goyang-si, Gyeonggi-do, Seongnam-si, Seoul
2023-01-01
Recruiting
Anthos Therapeutics, Inc.
Phase 3
2,500
Anyang-si, Busan, Daegu, Daejeon, Goyang-si, Gwangju, Gyeonggi-do, Seongnam-si
2022-12-27
Active, closed
Janssen Research & Development, LLC
Phase 3
214
Busan, Goyang-si, Hwasun, Seongnam, Seoul
2022-12-15
Active, closed
Janssen Research & Development, LLC
Phase 1/2
57
Cheongju-si, Goyang-si, Incheon, Jeollanam-do, Seongnam, Seoul
2022-12-13
Recruiting
Janssen Research & Development, LLC
Phase 2
520
Goyang-si, Seongnam-si, Seoul
2022-11-11
Recruiting
Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast Reconstruction
NCT05490433Breast Cancer Classified as TNM Stage 0-IIIa
Yonsei University
Not applicable
790
Changwon, Daegu, Goyang-si, Incheon, Pusan, Sejong, Seoul, Yongin-si
2022-10-26
Active, closed
Eli Lilly and Company
Phase 3
8,000
Busan, Cheonan-si, Cheongju-si, Daegu, Goyang-si, Gyeongsan-si, Hwasun-gun, Incheon
2022-10-04
By invitation
Comparison Study Between Suction Aspiration and Combination Technique in Acute Cerebral Infarction
NCT06254755Acute Cerebral Ischemia Requiring for Mechanical Thrombectomy
Inje University Haeundae Paik Hospital
Not applicable
1,132
Goyang-si, Seongnam-si, Changwon, Bucheon-si, Daegu, Daejeon, Incheon, Pohang
2022-10-01
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Busan, Daegu, Goyang-si, Gwangju, Gyeonggi-do, Seoul, Suwon
2022-09-13
Active, closed
Exelixis
Phase 3
901
Goyang-si, Gyeonggi-do, Hwasun, Seongnam-si, Seoul
2022-09-07
Active, closed
Yonsei University
Observational
260
Busan, Chuncheon, Ansan-si, Goyang-si, Yongin-si, Daegu, Yangsan, Jeonju
2022-08-31
Recruiting
Qurient Co., Ltd.
Phase 1/2
130
Daegu, Goyang-si, Seongnam-si, Seoul, Suwon
2022-08-30
Active, closed
Hoffmann-La Roche
Phase 3
139
Goyang-si, Seoul
2022-08-30
Recruiting
Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors
NCT05982691CNS Germinoma, CNS Tumor, Asian Consortium
National Cancer Center, Korea
Observational
400
Goyang-si
2022-08-05
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 1
220
Daegu, Goyang-si, Seongnam, Seoul
2022-08-04
Active, closed
Genentech, Inc.
Phase 3
373
Cheongju-si, Dongnam-gu, Cheonan-si, Goyang-si, Seongnam-si, Seoul
2022-08-03
Active, closed
AstraZeneca
Phase 3
341
Goyang-si, Gyeonggi-do, Jinju, Seoul, Suwon
2022-08-03
Recruiting
CHA University
Not applicable
240
Cheonan, Ansan-si, Goyang-si, Seongnam-si, Yangsan, Changwon, Hwasun, Busan
2022-08-01
Active, closed
Daewoong Pharmaceutical Co. LTD.
Phase 2
102
Busan, Bucheon-si, Goyang-si, Hwaseong-si, Seoul, Ulsan
2022-07-29
Recruiting
SupporTive Care At Home Research for Patients With Advanced Cancer (STAHR-cancer)
NCT05636384Malignant Neoplasm, Home Care Services, Quality of LIfe, Unplanned Hospitalization
Seoul National University Hospital
Not applicable
396
Goyang-si, Seongnam-si, Seoul
2022-07-25
Active, closed
PureTech
Phase 2
240
Bucheon-si, Goyang-si, Busan, Daegu, Gwangju, Gyeonggi-do, Incheon, Seoul
2022-07-22
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Busan, Daegu, Goyang-si, Gwangju, Hwaseong-si, Seongnam-si, Seoul, Suwon
2022-07-22
Recruiting
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
NCT05475925LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous Gamma-Delta T-Cell Lymphoma, Primary Cutaneous CD8+ Aggressive Epidermotropic T-Cell Lymphoma, Hepatosplenic T-cell Lymphoma
Dren Bio
Phase 1/2
200
Busan, Goyang-si, Seoul
2022-07-13
Active, closed
Pfizer
Phase 2
35
Goyang-si, Seoul
2022-07-07
Recruiting
Novartis Pharmaceuticals
Observational
900
Cheonan Si, Daegu, Goyang-si, Suwon, Gyeonggi-do, Seoul, Busan, Daejeon
2022-06-29
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 2/3
12
Goyang-si
2022-06-23
Recruiting
Nuvalent Inc.
Phase 1/2
840
Goyang-si, Seoul
2022-06-09
Recruiting
Astellas Pharma Inc
Phase 1
681
Goyang-si, Seongnam-si, Cheongju-si, Jongno -Gu, Seodaemun-gu, Songpa-gu, Seoul
2022-06-08
Recruiting
ImmuneOncia Therapeutics Inc.
Phase 1
86
Goyang-si, Seoul
2022-06-02
Active, closed
Novartis Pharmaceuticals
Observational
683
Daegu, Wŏnju, Bucheon-si, Bundang Gu, Goyang-si, Yangsan, Jeonju, Suncheon
2022-05-09
Active, closed
Novartis Pharmaceuticals
Observational
670
Daegu, Kangwon Do, Wŏnju, Goyang-si, Guri-si, Jinju, Jeonju, Iksan Si
2022-05-09
Recruiting
Cogent Biosciences, Inc.
Phase 3
482
Goyang-si, Seoul
2022-04-14
Active, closed
Janssen Research & Development, LLC
Phase 1/2
235
Goyang-si, Gwangju, Seoul
2022-04-11
Active, closed
CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER)
NCT05316181Epithelial Ovarian Cancer, Platinum Resistant, Recurrent Ovarian, HIPEC
National Cancer Center, Korea
Phase 3
140
Goyang-si, Seoul
2022-04-07
Active, closed
AstraZeneca
Phase 3
760
Busan, Daegu, Goyang-si, Junggu, Seoul
2022-03-28
Active, closed
AstraZeneca
Phase 3
1,035
Bukgu, Busan, Goyang-si, Seoul
2022-03-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Goyang-si, Seongnam, Songpagu, Seoul
2022-03-15
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Busan, Daegu, Gwangju, Goyang-si, Anyang, Hwasŏng, Seongnam, Seoul
2022-03-15
Recruiting
ORIC Pharmaceuticals
Phase 1/2
350
Cheongju-si, Goyang-si, Gyeonggi-do, Incheon, Seongnam-si, Seoul
2022-03-10
Active, closed
Daiichi Sankyo
Phase 2
187
Goyang-si, Seongnam-si, Seoul
2022-03-09
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Wŏnju, Goyang-si, Seongnam-si, Suwon, Cheongju-si, Seoul, Busan, Incheon
2022-03-07
Active, closed
Daiichi Sankyo
Phase 3
740
Seongnam-si, Jinju, Cheongju-si, Daegu, Goyang-si, Seoul, Songpa-gu
2022-03-04
Active, closed
AstraZeneca
Phase 3
791
Daegu, Goyang-si, Incheon, Jinju, Seoul, Suwon
2022-02-18
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 2
310
Goyang-si, Seoul
2022-02-17
Active, closed
UCB Biopharma SRL
Phase 3
113
Goyang-si
2022-02-02
Active, closed
Janssen Research & Development, LLC
Phase 3
350
Busan, Daegu, Daejeon, Dongdaemun-gu, Goyang-si, Gwangju, Gyeonggi-do, Seoul
2022-01-19
Active, closed
Eli Lilly and Company
Phase 3
152
Hwasun, Goyang-si, Seongnam, Busan, Seoul, Deagu
2021-12-20
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Anyang-si, Busan, Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2021-12-02
By invitation
National Cancer Center, Korea
Observational
128
Goyang-si
2021-11-15
Active, closed
National Cancer Center, Korea
Phase 2
30
Goyang-si
2021-11-15
Active, closed
AstraZeneca
Phase 3
454
Cheongju-si, Goyang-si, Gyeonggi-do, Seoul
2021-10-28
Active, closed
AstraZeneca
Phase 3
148
Daejeon, Goyang-si, Incheon, Seoul
2021-10-28
Active, closed
AstraZeneca
Phase 3
927
Goyang-si, Seoul
2021-10-25
Recruiting
Hoffmann-La Roche
Phase 1
542
Goyang-si, Jeollanam-do, Seongnam-si, Seoul
2021-10-22
Active, closed
Pfizer
Phase 3
77
Namdong-gu, Goyang-si, Seongnam, Seoul
2021-09-29
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Bucheon-si, Busan, Cheongju-si, Daegu, Daejeon, Gangseo-gu, Goyang-si, Incheon
2021-08-14
Active, closed
HUYABIO International, LLC.
Phase 3
450
Goyang-si, Seongnam-si, Seoul, Hwasun, Daejeon
2021-08-12
Active, closed
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
NCT04956640Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Endometrial Neoplasms, Ovarian Neoplasms
Eli Lilly and Company
Phase 1/2
540
Goyang-si, Suwon, Hwasun-gun, Seoul
2021-07-19
Active, closed
AstraZeneca
Phase 3
315
Cheonan-si, Daegu, Goyang-si, Seongnam-si, Seoul
2021-06-30
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Anyang-si, Busan, Daejeon, Goyang-si, Hwasun-gun, Seongnam-si, Seoul, Suwon
2021-06-24
Recruiting
Hoffmann-La Roche
Phase 1/2
316
Goyang-si, Seoul
2021-06-22
Active, closed
MIT-001 for Prevention of CCRT-Induced OM in HNSCC Patients
NCT04651634Head and Neck Squamous Cell Carcinoma, Oral Mucositis
DrugCCRT
MitoImmune Therapeutics
Phase 2
60
Suwon, Jeonju, Daegu, Daejeon, Goyang-si, Gyeonggi-do, Incheon, Seoul
2021-06-21
Recruiting
Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type
NCT04890171Stomach Cancer, Undifferentiated Type, Expanded Indication of Endoscopic Resection
National Cancer Center, Korea
Not applicable
708
Goyang-si
2021-06-11
Active, closed
Pfizer
Phase 3
599
Goyang-si, Hwasun-gun, Seongnam, Daegu, Seoul
2021-05-12
Active, closed
Incyte Corporation
Phase 3
899
Busan, Daegu, Goyang-si, Incheon, Jeonju, Jinju, Seoul, Yangsan
2021-05-11
Active, closed
AstraZeneca
Phase 3
893
Goyang-si, Seoul
2021-05-10
Recruiting
Ipsen
Phase 1/2
240
Goyang-si, Incheon, Seongnam-si, Seoul
2021-04-29
Active, closed
Hoffmann-La Roche
Phase 3
557
Goyang-si, Gyeonggi-do, Seoul
2021-04-26
Active, closed
AstraZeneca
Phase 3
1,157
Cheonan-si, Daegu, Goyang-si, Seoul
2021-04-26
Active, closed
IDEAYA Biosciences
Phase 1
169
Goyang-si, Seongnam-si, Cheongju-si, Seoul
2021-04-14
Active, closed
Hoffmann-La Roche
Phase 3
751
Daegu, Goyang-si, Seoul
2021-03-24
Recruiting
AstraZeneca
Phase 1
304
Cheongju-si, Goyang-si, Jinju, Seoul
2021-03-09
Recruiting
Seoul National University Hospital
Not applicable
90
Goyang-si, Seoul
2021-02-25
Active, closed
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
NCT04619004Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
Daiichi Sankyo
Phase 2
277
Songpa-gu, Cheongju-si, Daegu, Goyang-si, Seongnam, Seoul
2021-02-02
Active, closed
Pfizer
Phase 3
841
Goyang-si, Busan, Daegu, Incheon, Seoul
2020-12-21
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Busan, Daegu, Gangnam Gu, Goyang-si, Hwasun-gun, Namdong, Seoul, Yangsan
2020-12-07
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Busan, Cheongju-si, Daegu, Goyang-si, Junggu, Seoul, Suwon
2020-12-02
Active, closed
Hoffmann-La Roche
Phase 2
303
Dongnam-gu, Cheonan-si, Goyang-si, Seoul
2020-11-27
Active, closed
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
NCT04452591Non Muscle Invasive Bladder Cancer, High-grade Ta/ T1 Papillary Disease Bladder Cancer
CG Oncology, Inc.
Phase 3
190
Goyang-si, Busan, Gyeongsang, Jeongnam, Seoul
2020-10-27
Active, closed
Exelixis
Phase 3
575
Junggu, Goyang-si, Seongnam-si, Hwasun, Busan, Daegu, Gwangju, Seoul
2020-10-19
Active, closed
Acerta Pharma BV
Phase 3
611
Busan, Goyang-si, Jeonju, Seoul, Suwon
2020-10-08
Active, closed
AstraZeneca
Phase 3
370
Busan, Cheongju-si, Goyang-si, Seongnam-si, Seoul
2020-10-02
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
240
Goyang-si, Suwon, Jeonju, Busan, Daegu, Incheon, Seoul
2020-08-20
Active, closed
AstraZeneca
Phase 3
866
Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2020-07-24
Active, closed
AstraZeneca
Phase 3
1,012
Daegu, Goyang-si, Seongnam-si, Seoul
2020-07-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Goyang-si, Seongnam-si, Suwon, Jinju, Cheongju-si, Daegu, Seoul
2020-07-06
Recruiting
ECOG-ACRIN Cancer Research Group
Observational
770
Goyang-si, Seoul
2020-06-16
Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
NCT04389632Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma
Seagen, a wholly owned subsidiary of Pfizer
Phase 1
1,006
Goyang-si, Cheongju-si, Seoul
2020-06-08
Active, closed
AstraZeneca
Phase 3
805
Goyang-si, Seoul, Suwon, Yangsan
2020-05-05
Active, closed
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer
NCT04155034Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma
SWOG Cancer Research Network
Phase 3
668
Goyang-si
2020-05-04
Active, closed
L&C Bio
Not applicable
90
Goyang-si, Seoul
2020-04-16
Active, closed
AstraZeneca
Phase 3
818
Busan, Daegu, Goyang-si, Incheon, Seongnam-si, Seoul, Suwon
2020-04-16
Active, closed
Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery
NCT04585074Breast Neoplasms, Germline BRCA1 Gene Mutation, Germline BRCA2 Gene Mutation, Benign Breast Disease
Severance Hospital
Observational
2,000
Busan, Sejong, Daegu, Wŏnju, Ansan, Goyang-si, Yongin-si, Changwon
2020-04-08
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Daejeon, Goyang-si, Hwasun, Seongnam-si, Seoul
2020-03-30
Active, closed
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)
NCT04152499Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Urothelial Carcinoma
Klus Pharma Inc.
Phase 1/2
1,410
Seongnam-si, Busan, Daegu, Goyang-si, Gyeonggi-do, Incheon, Seoul
2020-02-28
Active, closed
Eli Lilly and Company
Phase 3
261
Goyang-si, Seongnam-si, Incheon, Seoul, Jinju, Dongjak-gu, Daejeon
2020-02-17
Active, closed
Loxo Oncology, Inc.
Phase 3
291
Jungbuk, Goyang-si, Seongnam, Seoul
2020-02-11
Active, closed
Pfizer
Phase 3
1,068
Goyang-si, Seongnam-si, Seoul, Daegu
2019-12-30
Active, closed
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer
NCT04036682Non Small Cell Lung Cancer, EGFR Exon 20 Mutation
Cullinan Therapeutics Inc.
Phase 1/2
284
Goyang-si, Gyeonggi-do, Incheon, Seoul, Soeul, Suwon
2019-10-31
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
466
Goyang-si, Seongnam-si, Seoul
2019-10-02
Active, closed
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT04095364Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma, Stage II Fallopian Tube Cancer AJCC v8
NRG Oncology
Phase 3
450
Goyang-si, Seoul, Seongnam, Daegu, Incheon
2019-09-20
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
NCT04104776Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant
Novartis Pharmaceuticals
Phase 1/2
300
Daegu, Goyang-si, Incheon, Seoul
2019-09-18
By invitation
National Cancer Center, Korea
Observational
5,000
Goyang-si
2019-07-03
Active, closed
AstraZeneca
Phase 3
923
Busan, Cheonan-si, Cheongju-si, Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2019-06-25
Active, closed
SCM Lifescience Co., LTD.
Observational
42
Bucheon-si, Daegu, Goyang-si, Gwangju, Incheon, Suwon
2019-05-10
Active, closed
AstraZeneca
Phase 2
367
Goyang-si, Seongnam-si, Seoul, Suwon
2019-01-09
Active, closed
AstraZeneca
Phase 2
401
Dongjakgu, Goyang-si, Seodaemun-gu, Seoul, Suweonsi Paldalgu
2018-12-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
714
Hwasun Gun, Goyang-si, Seongnam-si, Suwon, Seoul
2018-12-17
Active, closed
OBI Pharma, Inc
Phase 3
575
Busan, Goyang-si, Incheon, Seongnam-si, Seoul, Suwon
2018-12-05
Active, closed
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT03653507Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
507
Daegu, Goyang-si, Gyeonggi-do, Incheon, Jeollanam-do, Jeonju, Seongnam-si, Seoul
2018-11-28
Active, closed
AstraZeneca
Phase 3
1,063
Daegu, Goyang-si, Gyeonggi-do, Incheon, Seoul
2018-11-16
Active, closed
AstraZeneca
Phase 3
895
Daegu, Goyang-si, Seoul
2018-10-31
Active, closed
AbbVie
Phase 2
270
Goyang-si, Seongnam, Suwon, Yangsan, Incheon, Hwasun-gun, Cheongju-si, Seoul
2018-10-10
Active, closed
AstraZeneca
Phase 3
730
Changwon-si, Cheongju-si, Daegu, Goyang-si, Jinju, Seongnam-si, Seoul, Suwon
2018-09-27
Active, closed
AstraZeneca
Phase 3
1,246
Goyang-si, Incheon, Seoul, Suwon
2018-09-27
By invitation
National Cancer Center, Korea
Observational
120
Goyang-si
2018-09-21
By invitation
National Cancer Center, Korea
Observational
500
Goyang-si
2018-09-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Inceon, Hwasun, Goyang-si, Seongnam-si, Suwon, Cheongju-si, Gangnam-gu, Songpagu
2018-08-21
Active, closed
Gilead Sciences
Phase 2
502
Daegu, Goyang-si, Gwangju, Hwasun, Seongbuk-Gu, Seoul, Suwon, Wŏnju
2018-08-13
Active, closed
The Effect of Home Blood Pressure Measurement on the Management of Hypertension
NCT03868384Hypertension, Blood Pressure, Home Blood Pressure Measurement, Ambulatory Blood Pressure
DongGuk University
Observational
701
Goyang-si
2018-08-01
Recruiting
Xynomic Pharmaceuticals, Inc.
Phase 3
413
Goyang-si, Seongnam-si, Seoul
2018-07-17
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
Genmab
Phase 1/2
666
Busan, Daegu, Goyang-si, Jeonju, Seongnam-si, Seoul
2018-06-26
Active, closed
pharmaand GmbH
Phase 3
1,097
Goyang-si, Seongnam-si, Incheon, Cheonan, Seoul, Suwon
2018-05-14
Active, closed
Bristol-Myers Squibb
Phase 3
545
Suwon, Seoul, Daegu, Goyang-si, Gyeongsangnam-do, Jeollanam-do, Seongnam-si
2018-04-18
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Busan, Daejeon, Goyang-si, Gwangju, Gyeonggi-do, Incheon, Seoul, Wŏnju
2018-03-23
Active, closed
Yale University
Phase 2
190
Goyang-si, Gyeonggi-do, Seoul
2018-03-20
Active, closed
AstraZeneca
Phase 2
273
Cheongju-si, Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2018-03-07
Active, closed
Pfizer
Phase 3
1,054
Goyang-si, Busan, Daegu, Seoul
2017-12-18
Active, closed
Daehwa Pharmaceutical Co., Ltd.
Phase 2/3
549
Wŏnju, Goyang-si, Seongnam-si, Suwon, Cheongju-si, Busan, Daegu, Daejeon
2017-12-18
Recruiting
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
NCT03418961Cardiotoxicity, HER2/Neu Positive, Metastatic Malignant Neoplasm in the Brain, Recurrent Breast Carcinoma
SWOG Cancer Research Network
Phase 3
491
Goyang-si
2017-11-01
Active, closed
Samsung Medical Center
Not applicable
240
Goyang-si, Pusan, Seongnam, Seoul
2017-10-20
Active, closed
ECOG-ACRIN Cancer Research Group
Phase 3
108,508
Goyang-si
2017-09-28
Active, closed
Savolitinib vs. Sunitinib in MET-driven PRCC.
NCT03091192Carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms, Urologic Neoplasms
AstraZeneca
Phase 3
60
Daejeon, Goyang-si, Hwasun-gun, Incheon, Seoul
2017-07-25
Active, closed
Eli Lilly and Company
Phase 3
5,637
Cheongju-si, Cheonan-si, Incheon, Namdong-gu, Goyang-si, Seongnam, Busan, Haeundae-gu
2017-07-12
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
Institut de Recherches Internationales Servier
Phase 3
146
Goyang-si, Suwon, Busan, Seoul
2017-06-26
Active, closed
Eli Lilly and Company
Phase 1/2
857
Goyang-si, Seongnam, Seoul
2017-05-02
Active, closed
Samsung Medical Center
Observational
1,400
Daegu, Goyang-si, Seoul
2016-12-01
Active, closed
Eisai Inc.
Phase 3
1,069
Daegu, Goyang-si, Seoul
2016-10-13
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Busan, Daegu, Goyang-si, Hwasun-gun, Incheon, Seongnam-si, Seoul, Suwon
2016-09-13
Active, closed
Janssen Research & Development, LLC
Phase 1
751
Cheongju-si, Goyang-si, Incheon, Seongnam-si, Seoul
2016-05-24
Active, closed
AstraZeneca
Phase 1/2
264
Goyang-si, Seongnam-si, Seoul
2016-03-17
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Daegu, Daejeon, Goyang-si, Jeollanam-do, Seongnam-si, Seoul
2015-11-27
Active, closed
AstraZeneca
Phase 3
1,118
Busan, Changwon-si, Cheongju-si, Daegu, Daejeon, Goyang-si, Incheon, Jinju
2015-07-21
Active, closed
Janssen Research & Development, LLC
Phase 2
239
Daejeon, Goyang-si, Incheon, Seoul
2015-04-22
Active, closed
Eli Lilly and Company
Phase 3
493
Incheon, Goyang-si, Seongnam, Seoul, Daegu, Ulsan
2014-11-06
Active, closed
Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents
NCT02264678Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
AstraZeneca
Phase 1
358
Goyang-si, Seongnam-si, Seoul
2014-10-31
Active, closed
Eli Lilly and Company
Phase 3
453
Goyang-si, Incheon, Seoul, Seowon-Gu, Suwon, Ulsan
2014-10-03
Active, closed
AstraZeneca
Phase 1
344
Cheongju-si, Goyang-si, Seongnam-si, Seoul
2014-08-05
Active, closed
AstraZeneca
Phase 3
1,837
Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2014-04-22
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
Janssen Research & Development, LLC
Phase 3
539
Goyang-si, Seoul
2013-09-09
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
AstraZeneca
Phase 3
450
Goyang-si, Seoul
2013-08-26
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
Dongan, Seoul, Anyang-si, Goyang-si, Daegu, Gwangju, Gyeonggi-do, Jeju-do
2013-03-18
Active, closed
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
NCT01272037Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma
National Cancer Institute (NCI)
Phase 3
5,018
Goyang-si, Seongnam, Seoul
2011-02-28
Active, closed
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
NCT00565851Clear Cell Adenocarcinoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma
National Cancer Institute (NCI)
Phase 3
1,052
Dalseo-gu, Goyang-si, Seoul, Seongnam, Incheon, Suwon
2007-12-06
Active, closed
Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication
NCT01678027Gastric Cancer, Helicobacter Pylori Infection, Family Members
National Cancer Center, Korea
Phase 3
1,838
Goyang-si
2004-11
Active, closed
Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD
NCT02407119Helicobacter Pylori Infection, Early Gastric Cancer, Endoscopic Resection
National Cancer Center, Korea
Phase 3
470
Goyang-si
2003-06
Rows per page Showing 1–397 of 397
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 November 2026. https://priyalifescience.com/clinical-trials-south-korea/city/goyang-si

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,401 studies in total at the last sync on 13 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 397 of those studies with a site in Goyang-si.

How many clinical trials are recruiting in Goyang-si?

174 of the 397 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:18 UTC sync. A further 10 have not yet opened recruitment, 203 are active but closed to new participants, and 10 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Goyang-si), 397 studies
PhaseStudiesRecruitingShare
Phase 32318958.2%
Phase 2502012.6%
Observational32158.1%
Phase 1/227176.8%
Not applicable21125.3%
Phase 11994.8%
Phase 2/313113.3%
Phase 4411%

Most active sponsors

Lead sponsors with the most studies (Goyang-si)
Lead sponsorStudiesRecruiting
AstraZeneca7327
Merck Sharp & Dohme LLC3018
National Cancer Center, Korea2412
Janssen Research & Development, LLC206
Hoffmann-La Roche178
Pfizer134
AbbVie127
Daiichi Sankyo127
Eli Lilly and Company124
Bristol-Myers Squibb116
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.